ProCE Banner Activity

GEMINI-1/-2, STAT, TANGO, SALSA: Safety and Efficacy of DTG/3TC in Persons With HIV and Isolated Anti-HBc

Conference Coverage
Slideset

This retrospective analysis of 4 phase III/IIIb trials demonstrated virologic efficacy and safety of DTG/3TC in this population, with low incidence of elevated liver enzymes and no reactivation of HBV. 

Released: July 26, 2024

Expiration: July 25, 2025

Share

Faculty

Angela Davies

Angela Davies, MD

Assistant Professor of Medicine
UC Davis Cancer Center
Sacramento, CA

Amit “Mickey” Dhir

Amit “Mickey” Dhir, MBA, MSN, AGNP-C, AAHIVS

Infectious Disease Nurse Practitioner
Chase Brexton Health Care
Baltimore, Maryland

PT Faculty

Georgia Colangelo

Georgia Colangelo, RN, BSN, OCN

Collaborative Practice Nurse
Hillman Cancer Center
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS

ProCE Banner